Xing-jie Dai

75 Daxue Road
Zhengzhou, 450052, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Harnessing the quinoline core for targeted cancer therapy.

Harnessing the quinoline core for targeted cancer therapy.

Journal: Future medicinal chemistry

Published: August 13, 2026

Evolving CRBN ligands enhance the drug-like properties of protein degraders.

Evolving CRBN ligands enhance the drug-like properties of protein degraders.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: July 08, 2026

Pharmacological inhibition of LSD1 suppresses the CD155/TIGIT immune checkpoint axis and enhances NK cell-mediated cytotoxicity in colorectal cancer.

Pharmacological inhibition of LSD1 suppresses the CD155/TIGIT immune checkpoint axis and enhances NK cell-mediated cytotoxicity in colorectal cancer.

Journal: Bioorganic chemistry

Published: June 28, 2026

Targeting antibody-inaccessible immune resistance with small-molecule immunotherapy.

Targeting antibody-inaccessible immune resistance with small-molecule immunotherapy.

Journal: International immunopharmacology

Published: June 05, 2026

Small molecules targeting the PD-1/PD-L1 axis for cancer immunotherapy.

Small molecules targeting the PD-1/PD-L1 axis for cancer immunotherapy.

Journal: Theranostics

Published: January 03, 2026

Histone Deacetylase Meets Protein Degradation: Accelerating Anticancer Drug Discovery.

Histone Deacetylase Meets Protein Degradation: Accelerating Anticancer Drug Discovery.

Journal: Medicinal research reviews

Published: December 03, 2025

Identification of Novel Phenoxazine-Derived LSD1 Inhibitors Suppressing Gastric Cancer Stemness by β-Catenin Transcriptional Regulation.

Identification of Novel Phenoxazine-Derived LSD1 Inhibitors Suppressing Gastric Cancer Stemness by β-Catenin Transcriptional Regulation.

Journal: Journal of medicinal chemistry

Published: October 29, 2025

Decoding IL4I1: The Core role of metabolism-driven immune regulation and new perspectives on disease targeting.

Decoding IL4I1: The Core role of metabolism-driven immune regulation and new perspectives on disease targeting.

Journal: Bioorganic chemistry

Published: October 24, 2025

Unveiling the power of quinazoline derivatives: a new frontier in targeted cancer therapy.

Unveiling the power of quinazoline derivatives: a new frontier in targeted cancer therapy.

Journal: Bioorganic & medicinal chemistry

Published: September 25, 2025

Multiple gastric cancer tissue proteomic identification predicts CLU as a biomarker for anti-PD-1 immunotherapy.

Multiple gastric cancer tissue proteomic identification predicts CLU as a biomarker for anti-PD-1 immunotherapy.

Journal: Journal of pharmaceutical analysis

Published: September 07, 2025

Accelerating Small Molecule Ferroptosis Regulator Development With Advances in Biological Functions.

Accelerating Small Molecule Ferroptosis Regulator Development With Advances in Biological Functions.

Journal: Medicinal research reviews

Published: February 21, 2025

Synthesis, cytotoxicity and HQSAR study of amides-fused isosteviol derivatives as potential anti-colorectal cancer agents.

Synthesis, cytotoxicity and HQSAR study of amides-fused isosteviol derivatives as potential anti-colorectal cancer agents.

Journal: Fitoterapia

Published: November 25, 2024

Showing 1-12 of 29

Last Updated: 09/26/2026